Reply to "Liver transplantation using hepatitis B core positive grafts: Which is the optimal antiviral prophylaxis?"

J Hepatol. 2019 Sep;71(3):636-637. doi: 10.1016/j.jhep.2019.06.006. Epub 2019 Jun 21.

Authors

Tiffany Wong¹, James Fung²

Affiliations

¹ Department of Surgery, The University of Hong Kong, Hong Kong; Department of Surgery, Queen Mary Hospital, Hong Kong; Department of Surgery, The University of Hong Kong-Shenzhen Hospital, China.
² Department of Medicine, The University of Hong Kong, Hong Kong; Department of Medicine, Queen Mary Hospital, Hong Kong. Electronic address: [email protected].

PMID: 31230832
DOI: 10.1016/j.jhep.2019.06.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents*
Hepatitis B Core Antigens
Hepatitis B*
Humans
Liver Transplantation*

Substances

Antiviral Agents
Hepatitis B Core Antigens